Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Cancer Letters|March 6, 2023
MUC1-C is necessary for SHP2 activation and BRAF inhibitor resistance in BRAF(V600E) mutant colorectal cancerYoshihiro Morimoto, Nami Yamashita, Haruka Hirose, et al.
Pathology International|March 5, 2025
A Proposal for a Modified Evaluation System of Tumor-Infiltrating Lymphocytes Using HE-Stained Sections in Breast CancerRyo Kikuchi, Hoshiho Kubota, Yuuki Nishimura, et al.
Cancer Letters|February 14, 2026
M1C Mediates LINE-1 Transcription in PARP Inhibitor-Treated Prostate Cancer CellsKeisuke Shigeta, Shinkichi Takamori, Hiroki Ozawa, et al.
Cancer Research|December 16, 2020
MUC1-C Activates the BAF (mSWI/SNF) Complex in Prostate Cancer Stem CellsMasayuki Hagiwara, Yota Yasumizu, Nami Yamashita, et al.
Molecular Cancer Research : MCR|January 13, 2022
MUC1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in Cancer Stem CellsAtrayee Bhattacharya, Atsushi Fushimi, Nami Yamashita, et al.
Journal for Immunotherapy of Cancer|February 8, 2023
MUC1-C is a master regulator of MICA/B NKG2D ligand and exosome secretion in human cancer cellsYoshihiro Morimoto, Nami Yamashita, Tatsuaki Daimon, et al.
Oncoimmunology|February 7, 2022
MUC1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancerMasayuki Hagiwara, Atsushi Fushimi, Atrayee Bhattacharya, et al.
Pageof 5